← FDA Drug Approvals (Drugs@FDA)

LANREOTIDE ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2026-09-18

Drug application

FDA Application #

ANDA218217

Application type

Abbreviated New Drug Application (Generic)

Brand name

LANREOTIDE ACETATE

Generic name

Lanreotide Acetate

Active ingredients

LANREOTIDE ACETATE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

AMNEAL

First approval

2026-09-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown